<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="44530">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02526589</url>
  </required_header>
  <id_info>
    <org_study_id>R15042</org_study_id>
    <nct_id>NCT02526589</nct_id>
  </id_info>
  <brief_title>Does Bloody Urine Predict Urethrovesical Anastomosis Leakage After Radical Prostatectomy</brief_title>
  <official_title>Does Bloody Urine Predict Urethrovesical Anastomosis Leakage After Radical Prostatectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tampere University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Traditionally the watertightness of urethrovesical anastomosis after robotic radical
      prostatectomy is controlled by cystogram. However, clinical observations and one previous
      study showed that patients with anastomotic leakage have red coloured urine. If the
      investigators can verify this finding, the most of the cystograms can be avoided. In this
      study the investigators estimate urine colour after cystogram and take a picture from urine
      collecting pag. Later on the pictures are digitally analyzed and compared to cystogram
      finding.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">May 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Urine colour</measure>
    <time_frame>1 week</time_frame>
    <description>correlation of urine colour to cystogram finding</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">201</enrollment>
  <condition>Prostatic Neoplasm</condition>
  <condition>Anastomosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Robotic assisted laparoscopic radical prostatectomy patients. Catheter removal visit.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Previous robotic radical prostatectomy

          -  Catheter removal visit

        Exclusion Criteria:

          -  No urine in urinary collecting bag
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jarno Riikonen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tampere University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jarno Riikonen, MD</last_name>
    <email>jarno.riikonen@tays.fi</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jarno Riikonen, MD, PhD</last_name>
      <email>jarno.riikonen@tays.fi</email>
    </contact>
    <contact_backup>
      <last_name>Teemu Murtola, MD, PhD</last_name>
      <email>teemu.murtola@uta.fi</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 20, 2017</lastchanged_date>
  <firstreceived_date>August 10, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
